Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Structure and Function of Platelets01:18

Structure and Function of Platelets

2.7K
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
2.7K
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

8.5K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
8.5K
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

8.1K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
8.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lack of association between vaccine-induced immune thrombocytopenia and thrombosis and HLA loci in a large cohort.

British journal of haematology·2026
Same author

Blinatumomab in Combined Immune Thrombocytopenia and Antiphospholipid Syndrome.

The New England journal of medicine·2026
Same author

Adenoviral Inciting Antigen and Somatic Hypermutation in VITT.

The New England journal of medicine·2026
Same author

Advances in our understanding of anti-PF4 related immunothrombosis.

Frontiers in immunology·2026
Same author

Demographics and donor motivation drive declining blood donations: A 15-year study in Germany reflecting trends in high-income countries.

Vox sanguinis·2026
Same author

Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT)-like Syndrome: A Case Report and Some Considerations on a Novel Diagnostic and Therapeutic Challenge.

Diagnostics (Basel, Switzerland)·2026

Related Experiment Video

Updated: Dec 27, 2025

Analyzing Platelet Subpopulations by Multi-color Flow Cytometry
08:04

Analyzing Platelet Subpopulations by Multi-color Flow Cytometry

Published on: June 10, 2025

1.2K

Large and small platelets-(When) do they differ?

Stefan Handtke1, Thomas Thiele1

  • 1Institut für Immunologie und Transfusionsmedizin, Abteilung Transfusionsmedizin, Universitätsmedizin Greifswald, Greifswald, Germany.

Journal of Thrombosis and Haemostasis : JTH
|February 29, 2020
PubMed
Summary
This summary is machine-generated.

Mean platelet volume (MPV) indicates platelet size and reactivity. This review examines the complex relationship between platelet size, thrombogenicity, age, and various diseases, clarifying existing controversies.

Keywords:
autoimmune diseasecardiovascular diseasecell sizemean platelet volumeplateletsthrombosis

More Related Videos

Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets
05:49

Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets

Published on: November 29, 2024

1.1K
Routine Screening Method for Microparticles in Platelet Transfusions
09:49

Routine Screening Method for Microparticles in Platelet Transfusions

Published on: January 31, 2018

16.4K

Related Experiment Videos

Last Updated: Dec 27, 2025

Analyzing Platelet Subpopulations by Multi-color Flow Cytometry
08:04

Analyzing Platelet Subpopulations by Multi-color Flow Cytometry

Published on: June 10, 2025

1.2K
Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets
05:49

Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets

Published on: November 29, 2024

1.1K
Routine Screening Method for Microparticles in Platelet Transfusions
09:49

Routine Screening Method for Microparticles in Platelet Transfusions

Published on: January 31, 2018

16.4K

Area of Science:

  • Hematology
  • Immunology
  • Cardiovascular Medicine

Background:

  • Platelets are crucial for hemostasis, inflammation, and immune responses.
  • Mean Platelet Volume (MPV) is a measure of average platelet size.
  • Historically, larger platelets were considered younger and more reactive, but this concept is debated.

Purpose of the Study:

  • To review current literature on platelets of varying sizes.
  • To discuss controversies surrounding large and small platelets.
  • To focus on platelet thrombogenicity, age, and the association of MPV with diseases.

Main Methods:

  • Literature review of studies investigating platelet size and MPV.
  • Analysis of research on platelet thrombogenicity and age.
  • Examination of MPV associations with various medical conditions.

Main Results:

  • Contradictory findings exist regarding the significance of platelet size and MPV.
  • MPV changes are observed in immune thrombocytopenia, cardiovascular diseases, and cancer.
  • Platelet size may correlate with thrombogenicity and cellular age, but evidence is complex.

Conclusions:

  • The role of platelet size and MPV in disease pathogenesis requires further clarification.
  • Understanding MPV variations is important for diagnosing and managing thrombotic and inflammatory conditions.
  • Future research should aim to resolve controversies surrounding platelet size and its clinical implications.